Abstract
Familial hypercholesterolemia is an inherited disease in humans that is caused by a deficiency in the receptor that mediates the internalization and degradation of low density lipoprotein. Patients that inherit two abnormal low density lipoprotein receptor alleles have severe hypercholesterolemia, advanced atherosclerosis, and life-threatening coronary artery disease that is refractory to conventional therapies. In this review, we discuss the prospects for gene therapy in the treatment of familial hypercholesterolemia.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Albumins / deficiency
-
Albumins / genetics
-
Animals
-
Asialoglycoproteins*
-
Cholesterol, LDL / metabolism
-
Disease Models, Animal
-
Gene Expression Regulation
-
Genetic Therapy*
-
Genetic Vectors
-
Homozygote
-
Humans
-
Hyperlipoproteinemia Type II / genetics
-
Hyperlipoproteinemia Type II / metabolism
-
Hyperlipoproteinemia Type II / therapy*
-
Lipoproteins, LDL / metabolism
-
Liposomes / administration & dosage
-
Liver / metabolism
-
Liver Transplantation
-
Mice
-
Mice, Transgenic
-
Orosomucoid / administration & dosage
-
Orosomucoid / analogs & derivatives
-
Rabbits / genetics
-
Rats
-
Rats, Mutant Strains / genetics
-
Receptors, LDL / deficiency
-
Receptors, LDL / genetics*
-
Receptors, LDL / metabolism
-
Recombinant Fusion Proteins / genetics
-
Recombinant Fusion Proteins / metabolism
Substances
-
Albumins
-
Asialoglycoproteins
-
Cholesterol, LDL
-
Lipoproteins, LDL
-
Liposomes
-
Orosomucoid
-
Receptors, LDL
-
Recombinant Fusion Proteins
-
asialoorosomucoid